Finance News – Trpv3 Inhibitor

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Tariffs Ceo Cryptocurrency Crypto Assets Stocks Investors Stock Stock Market Shares Ethereum Markets Price Xrp Investment Blockchain Sec Eth Stablecoin Etf Trade Earnings Revenue Solana Index China Bse Coinbase Token Nasdaq Ipo Wall Street Usd Trade War Inflation Interest Rates Economy Profit Digital Assets Sensex Sp 500 Nvidia Gold Binance Federal Reserve Treasury Nse Traders Logistics Invoices Domestic Film Car Plants Pretty Little Thing Mortgage Holders Financial Crime Compliance Economic Information Underlying Demand Texas Senate

Filter by:

Trpv3 Inhibitor ×

Business Insider Markets • Jun 03, 2025

Kamari Pharma Announces Closing of $23 Million Financing to Advance its First-In-Class Oral TRPV3 In...

Kamari Pharma secured $23 million in funding led by BRM Group and Pontifax to support the clinical development of its novel oral TRPV3 inhibitor targeting rare genetic skin conditi...

Read Full Article →